JD Health prices HK$27bn IPO high on strong investor support

Jonathan Breen

December 02, 2020 06:00 am

JD Health International has raised HK$27bn ($3.5bn) after sealing its IPO at the top end of the marketed range, following a flood of global investor demand.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

CITIC Securities Equity IPOs Health and Biotech UBS Equity China Merchants Bank Co China Jefferies LLC Hong Kong SAR ICBC Asia Greater China Bank of Communications Haitong Securities Northeast Asia Guotai Junan Securities Co Asia Pacific SRI DBS Bank of America Mizuho Emerging Markets Goldman Sachs

JB

Jonathan Breen

Equities editor GlobalCapital Asia